Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0220723 (
PCA
)
4,687
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a consecutive series, 209 preterm infants with birth weights below 1501 g or a gestational age of < or = 32 weeks were observed. Stage 3
retinopathy of prematurity
(
ROP
) developed in 48 infants (23%) of between 32 and 46 weeks postconceptional age (
PCA
; mean, 37 weeks). Stage 3
ROP
was not seen before 6 weeks after birth. Threshold
ROP
was seen and treated at between 34 and 42 weeks
PCA
(mean, 38 weeks
PCA
; n = 22, 10.5%). A subgroup of 126 untreated infants were followed until complete retinal vascularisation. At estimated term, 38.7% of eyes with vessels ending in zone 3 at the first examination showed complete vascularisation as compared with 17.6% of eyes with vessels ending in peripheral zone 2 and none of those with vessels ending in central zone 2. Occurrence of
ROP
delayed retinal development. At estimated term, no eye with any stage of
ROP
showed complete vascularisation as compared with 35.4% of eyes without
ROP
. Regression of stage 3
ROP
below threshold started in all cases before 56 weeks
PCA
.
...
PMID:Natural course of retinal development in preterm infants without threshold retinopathy. 766 25